BIOTRICITY INC. (BTCY) Executive Compensation
BIOTRICITY INC. (BTCY) is a publicly traded company on the OTC, categorized under SIC 3841 (Surgical & Medical Instruments & Apparatus). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: BTCY
CIK: 1630113
Exchange: OTC
SIC 3841: Surgical & Medical Instruments & Apparatus
Fiscal Year End: 03/31
State: NV
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
SRCO Professional Corporation
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerSameer Parekh
Audit LocationRichmond Hill, Canada
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| RW | 2026-10-07 | — | RW | 0001493152-26-046137 | View SEC Doc Filr Page |
| 8-K | 2026-09-28 | 2026-09-22 | 8-K | 0001493152-26-044407 | View SEC Doc Filr Page |
| 10-Q | 2026-08-19 | 2026-06-30 | 10-Q | 0001493152-26-039209 | View SEC Doc Filr Page |
| NT 10-Q | 2026-08-17 | 2026-06-30 | NT 10-Q | 0001493152-26-038710 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001753926-26-001518 | View SEC Doc Filr Page |
| 10-K | 2026-07-14 | 2026-03-31 | 10-K | 0001493152-26-033207 | View SEC Doc Filr Page |
| NT 10-K | 2026-06-29 | 2026-03-31 | NT 10-K | 0001493152-26-030382 | View SEC Doc Filr Page |
| DEF 14C | 2026-06-16 | 2026-06-15 | DEF 14C | 0001493152-26-028773 | View SEC Doc Filr Page |
| PRE 14C | 2026-05-29 | 2026-05-29 | PRE 14C | 0001493152-26-026356 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-12 | — | SCHEDULE 13G/A Filing | 0001753926-26-000825 | View SEC Doc Filr Page |
| 8-K | 2026-05-01 | 2026-05-01 | 8-K | 0001493152-26-020939 | View SEC Doc Filr Page |
| 8-K | 2026-02-18 | 2026-02-11 | 8-K | 0001493152-26-007369 | View SEC Doc Filr Page |
| 10-Q | 2026-02-11 | 2025-12-31 | 10-Q | 0001493152-26-006211 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-02-04 | — | SCHEDULE 13G/A Filing | 0001753926-26-000259 | View SEC Doc Filr Page |
| S-1 | 2025-12-19 | — | S-1 | 0001493152-25-028614 | View SEC Doc Filr Page |
| 8-K | 2025-11-18 | 2025-11-14 | 8-K | 0001493152-25-024061 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2025-11-14 | — | SCHEDULE 13G/A Filing | 0001753926-25-001799 | View SEC Doc Filr Page |
| 10-Q | 2025-11-14 | 2025-09-30 | 10-Q | 0001493152-25-023361 | View SEC Doc Filr Page |
| 10-Q | 2025-08-14 | 2025-06-30 | 10-Q | 0001641172-25-023709 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2025-08-12 | — | SCHEDULE 13G/A Filing | 0001753926-25-001292 | View SEC Doc Filr Page |
| 10-K/A | 2025-07-18 | 2025-03-31 | 10-K/A | 0001641172-25-020105 | View SEC Doc Filr Page |
| 10-K | 2025-07-15 | 2025-03-31 | 10-K | 0001641172-25-019755 | View SEC Doc Filr Page |
| NT 10-K | 2025-07-01 | 2025-03-31 | NT 10-K Filing | 0001641172-25-017241 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2025-05-15 | — | SCHEDULE 13G/A Filing | 0001753926-25-000848 | View SEC Doc Filr Page |
| 8-K | 2025-02-24 | 2025-02-20 | 8-K Filing | 0001493152-25-007938 | View SEC Doc Filr Page |